To compare the impact of microdebrider assisted inferior turbinoplasty vs inferior turbinate cauterization

To compare the impact of microdebrider assisted inferior turbinoplasty vs inferior turbinate cauterization on the quality of life of children

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131020015083N3

Enrollment

Registered

2021-11-30

Start date

2021-11-23

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with hypertrophy of nasal turbinates. Hypertrophy of nasal turbinates

Interventions

Intervention 1: Intervention group: microdebrider assisted inferior turbinoplasty. Intervention 2: Intervention group: inferior turbinate cauterization.

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: inferior turbinate hypertrophy nasal congestion Existence of rhinorrhea Failure to respond to medications including oral or topical corticosteroids, antihistamines

Exclusion criteria

Exclusion criteria: Age more than 18 years Adenoid hypertrophy Nasal polyps Severe deviation of the nasal septum

Design outcomes

Primary

Measure	Time frame
Patients' quality of life. Timepoint: 1, 3 and 6 months after surgery. Method of measurement: SNOT-22 Questionnaire.;Presence of crust in nasal cavity. Timepoint: Up to 1 week after surgery. Method of measurement: Anterior rhinoscopy.	—

Secondary

Measure	Time frame
Postoperative nasal bleeding. Timepoint: Up to 1 week after surgery. Method of measurement: Anterior rhinoscopy.;Facial pain. Timepoint: Up to 1 week after surgery. Method of measurement: Question from the patient.;Bad smell in nose. Timepoint: Up to 1 week after surgery. Method of measurement: Question from the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Tayebeh Kazemi

Shiraz University of Medical Sciences

tayyebe.kazemi@gmail.com+98 71 3629 1470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026